Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls - Wikidata - wikimedia - TriplyDB

Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls

Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls

http://www.wikidata.org/entity/Q24681441

about

PHF20 is an effector protein of p53 double lysine methylation that stabilizes and activates p53 Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma Biomarkers of pediatric brain tumors Crystal structures of the Tudor domains of human PHF20 reveal novel structural variations on the Royal Family of proteins Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries Identification of a human glioma antigen, SOX6, recognized by patients' sera.Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation.Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%.Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.Dendritic cell-based immunotherapy of malignant gliomas.Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients.Expression of PHF20 protein contributes to good prognosis of NSCLC and is associated with Bax expression.Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination PHF20 Readers Link Methylation of Histone H3K4 and p53 with H4K16 Acetylation.Improving seroreactivity-based detection of glioma.PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65 Cancer immunoediting in malignant glioma.Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line Combining gene expression signatures and autoantibody profiles in human meningioma.PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4.

P2860

Q24594648-28DED0CC-335F-4EAC-9CC3-96D59875D3A7 Q24615166-2A77E634-D32C-40D5-B6BA-97784BF2DEE7 Q26849656-8C02E38B-C005-4A7E-BF5D-885A5A729AAD Q27678211-754EE361-2B28-41F7-9CC6-9B2866C626E4 Q28178383-061F1A64-6D32-4F72-9DBD-6D5CE8D50FB0 Q31033978-24F5CF2D-5398-4EFB-8B41-967F768F94C7 Q33269548-17E4F226-6D5D-4646-AB3A-537ECAAB918B Q33334409-29358B26-A92E-451E-AF84-954EF034834E Q33588789-4D356BBB-D9EF-4688-AD62-F4E48F844EA6 Q33686433-9DC88113-552A-4269-BF19-445AE49319D2 Q35922426-4656761F-19F6-4EDD-8AA1-16B469BC1048 Q35955393-5243B024-97FE-4086-8373-19EB8DAC147B Q36375060-9BEF6A0D-4733-494D-93E9-1EE88B138D1A Q37091343-D709B652-036B-4DBD-94F6-4AA85A073D27 Q37446336-0F146FFA-B3E7-427B-AA3D-D7C4F888F687 Q37478666-C712B495-4600-42BD-8F78-539F574096EB Q37618064-91EA6E41-6CE0-4CB0-B94F-1470EAE2C419 Q37986999-5961D290-35B0-4499-845E-B5D324159B9A Q42370510-98A7ACC4-752C-4509-A300-34ADBAC28ED9 Q45879684-4BB8115D-ACC0-4E88-85DE-915654BD62D0 Q49922514-D7A0F7F1-AF16-4167-B003-0F153BFC2E34

P2860

Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls

http://www.wikidata.org/entity/Q24681441

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@ast

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@en

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@nl

type

label

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@ast

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@en

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@nl

prefLabel

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@ast

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@en

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@nl

P1433

Q24681441-A7D84285-615E-45E7-9420-0D4DD737754D

P1476

Q24681441-27D5679C-883C-42D0-A6F7-3E3B84C56989

P2093

Q24681441-0CC90940-DB7E-4AA2-9DF4-B09F4EB09593

Q24681441-1A46669D-BE06-4E14-A2BC-52B3C249577F

Q24681441-1BB5E2B7-B5CF-4CB6-83E7-642ADD801D92

Q24681441-32B61F9A-53D3-4B7E-9F5D-86879A578578

Q24681441-B867E18B-1B21-4460-B330-874F691BE117

P2860

Q24681441-0B8BD75B-1183-432C-B497-D27767BB20E5

Q24681441-0F0DA33D-7A8E-4A10-BCEC-C95DDA846FB4

Q24681441-1C168367-6EEA-4E79-8941-033207E72554

Q24681441-26A222B1-200B-4790-9138-98C5FD59062A

Q24681441-82A13017-DDF4-4C9B-A0ED-597D471033F6

Q24681441-846104EC-7A9A-4E9D-88EA-CDF59AC27AA2

Q24681441-8C88C012-1246-4B64-9D59-9352ED9C6311

Q24681441-8D6A734E-32C3-40D9-975B-4C2A05800910

Q24681441-BD083046-6135-47B7-B2F9-C830274C1DFA

Q24681441-C8E7A1B9-3A5C-4D2C-B397-687194A28772

P304

Q24681441-6CE6376F-C21A-4312-B15D-4936F9B3B9D2

P31

Q24681441-F9E97E81-3488-48CF-8DC4-BD8319030547

P356

Q24681441-7B20E263-EF36-4D8C-8FDD-7C7F24DFDF53

P407

Q24681441-335123D7-692D-40DB-943C-FE5DB99B71DB

P433

Q24681441-4A0006F6-9912-416C-A629-B46900F0B2E8

P478

Q24681441-AA7DFBDC-51B9-4F54-B4CC-4604A3A7B977

P50

Q24681441-D6300DE9-5142-4390-88BB-AFC3C69259FD

P577

Q24681441-C41B9F47-47D7-4E2D-957B-BA0934E044E9

P5875

Q24681441-5CEA72C6-58CD-4FF9-966C-62F7792BCBE5

P698

Q24681441-3498024C-6FF8-4C9F-9B2F-FFFA75DF223B

P932

Q24681441-77E683B8-B6CC-4E02-9C27-9C958A415D1E

P356

J.1365-2249.2001.01635.X

P1433

Clinical and Experimental Immunology

P1476

Glioma-expressed antigen 2 (GL ...... oma patients and some controls

@en

P2093

A K Struss

http://www.w3.org/2001/XMLSchema#string

D Hemmer

http://www.w3.org/2001/XMLSchema#string

E Meese

http://www.w3.org/2001/XMLSchema#string

U Fischer

http://www.w3.org/2001/XMLSchema#string

W I Steudel

http://www.w3.org/2001/XMLSchema#string

P2860

cDNA cloning and chromosomal mapping of a predicted coiled-coil proline-rich protein immunogenic in meningioma patients

Human neoplasms elicit multiple specific immune responses in the autologous host

"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum

Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses

Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989.

Tumor antigens in astrocytic gliomas.

P304

206-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2249.2001.01635.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

Christian P. Pallasch

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11652062

http://www.w3.org/2001/XMLSchema#string

P698

11703362

http://www.w3.org/2001/XMLSchema#string

P932

1906187

http://www.w3.org/2001/XMLSchema#string